Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Regenerative Medical Technology (RMTG) Shares Outstanding (2017 - 2025)

Historic Shares Outstanding for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $12.5 million.

  • Regenerative Medical Technology's Shares Outstanding changed 0.0% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $12.5 million for FY2024, which is 36.04% up from last year.
  • Per Regenerative Medical Technology's latest filing, its Shares Outstanding stood at $12.5 million for Q3 2025, which was down 0.0% from $12.5 million recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Shares Outstanding peaked at $12.5 million during Q3 2024, and registered a low of $10.9 million during Q1 2021.
  • For the 5-year period, Regenerative Medical Technology's Shares Outstanding averaged around $12.3 million, with its median value being $12.4 million (2022).
  • Data for Regenerative Medical Technology's Shares Outstanding shows a peak YoY increase of 3117.89% (in 2021) and a maximum YoY decrease of 2446.8% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Shares Outstanding stood at $12.1 million in 2021, then increased by 2.97% to $12.4 million in 2022, then increased by 0.4% to $12.5 million in 2023, then rose by 0.36% to $12.5 million in 2024, then changed by 0.0% to $12.5 million in 2025.
  • Its last three reported values are $12.5 million in Q3 2025, $12.5 million for Q2 2025, and $12.5 million during Q1 2025.